Daniell Richard (CIK 0001726096)

Latest company ownership

Role: Exec. VP, European Commercial
Shares held
69,182
Last filed at
Mar 7, 2025
Confidence Score
25.0
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 9, 2025 Dec 11, 2025 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 17.5 -115,468 -70.47% $3.3M
Mar 5, 2025 Mar 7, 2025 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 5.0 -70,961 -59.46% $1.1M
Mar 4, 2025 Mar 6, 2025 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 5.0 -140,372 -36.68% $2.2M
Mar 3, 2025 Mar 5, 2025 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 7.5 -62,250 -100.00% $999.4K
Aug 12, 2024 Aug 13, 2024 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 17.5 -98,943 -100.00% $1.7M
Mar 5, 2024 Mar 7, 2024 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 12.5 -48,629 -22.37% $657.2K
Mar 3, 2024 Mar 5, 2024 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 5.0 -95,762 -40.70% $1.3M
Feb 28, 2024 Mar 1, 2024 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 12.5 -20,599 -22.79% $270.2K
Mar 6, 2023 Mar 8, 2023 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 7.5 -72,009 -50.79% $687.9K
Feb 28, 2023 Mar 2, 2023 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 7.5 -44,252 -28.15% $437.5K
Mar 4, 2022 Mar 8, 2022 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 7.5 -58,952 -35.60% $438.5K
Feb 28, 2022 Mar 2, 2022 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 10.0 -20,598 -50.39% $167.7K
Feb 9, 2022 Feb 10, 2022 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 10.0 -13,135 -39.31% $119K
Mar 4, 2021 Mar 8, 2021 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 10.0 -7,513 -27.03% $79.5K
Mar 3, 2021 Mar 4, 2021 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 32.5 -993 -7.72% $10.8K
Feb 28, 2021 Mar 2, 2021 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 10.0 -20,598 -65.68% $223.5K
Feb 9, 2021 Feb 11, 2021 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 7.5 -13,135 -54.96% $870.4K
Sep 9, 2020 Sep 10, 2020 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 42.5 -333 -3.00% $3K
Mar 17, 2020 Mar 19, 2020 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 37.5 -616 -5.59% $4.4K
Mar 3, 2020 Mar 5, 2020 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 32.5 -991 -9.25% $11.7K
Feb 9, 2020 Feb 11, 2020 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 10.0 -6,199 -41.85% $75.9K
Sep 18, 2019 Sep 20, 2019 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 47.5 -1,176 -41.23% $9.2K
Sep 9, 2019 Sep 11, 2019 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 47.5 -333 -47.84% $2.4K
Mar 17, 2019 Mar 19, 2019 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 26.3 -1,297 -100.00% $21.6K
Mar 12, 2019 Mar 14, 2019 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 26.3 -715 -100.00% $11.2K
Mar 3, 2019 Mar 5, 2019 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 26.3 -2,098 -100.00% $35.4K
Sep 18, 2018 Sep 20, 2018 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 22.5 -2,488 -100.00% $58.9K
Sep 9, 2018 Sep 11, 2018 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 26.3 -696 -100.00% $14.8K
Mar 17, 2018 Mar 20, 2018 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 26.3 -1,297 -100.00% $23.2K
Mar 12, 2018 Mar 14, 2018 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 26.3 -714 -100.00% $13.9K
Mar 3, 2018 Mar 6, 2018 TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Sell 26.3 -2,098 -100.00% $40.4K